আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
atorvastatin xiromed (tinavast) filmuhúðuð tafla 80 mg
medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 80 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
atorvastatin xiromed (tinavast) filmuhúðuð tafla 20 mg
medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 20 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
atorvastatin xiromed (tinavast) filmuhúðuð tafla 10 mg
medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 10 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
atorvastatin xiromed (tinavast) filmuhúðuð tafla 40 mg
medical valley with subfirm xiromed - atorvastatin kalsíum tríhýdrat - filmuhúðuð tafla - 40 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
amiloride/hct alvogen (diuramin) tafla 5/50 mg
alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 5/50 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
amiloride/hct alvogen (diuramin mite) tafla 2,5/25 mg
alvogen ehf. - amiloridum hýdróklóríð; hydrochlorothiazidum inn - tafla - 2,5/25 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - bóluefni - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
sevelamercarbonat stada filmuhúðuð tafla 800 mg
stada arzneimittel ag - sevelamerum karbónat - filmuhúðuð tafla - 800 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
abilify maintena
otsuka pharmaceutical netherlands b.v. - aripíprazól - geðklofa - psycholeptics - viðhald meðferð geðklofa í fullorðinn sjúklingar stöðug með inntöku sjúklingum.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
kolbam
retrophin europe ltd - cholic sýru - umbrot, innfæddir villur - galla og lifrarmeðferð - cholic sýru fgk er ætlað fyrir meðferð meðfæddan villur af aðal galli sýru myndun, í ungabörn frá einum mánuði aldri fyrir samfelld ævilangt meðferð í gegnum fullorðinsár, tekur eftir einn ensím galla:steról 27-hýdroxýlkljúfs (kynna eins og cerebrotendinous xanthomatosis, ctx) skort;2- (eða alfa-) methylacyl-str racemase (amacr) skort;kólesteról 7 alfa-hýdroxýlkljúfs (cyp7a1) skort.